SI
BCRX icon

SII Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History

SII Investments’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,000
Closed -$110K – 482
2014
Q1 		$110K Sell
12,000
-700
-6% -$7.46K 0.02% 405
2013
Q4 		$100K Sell
12,700
-100
-0.8% -$633 0.02% 421
2013
Q3 		$92K Sell
12,800
-4,100
-24% -$20.8K 0.02% 319
2013
Q2 		$28K Buy
+16,900
New +$29.2K 0.01% 380

Other funds holding BCRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

SII Investments's BCRX Position: Q2 2014 in Review

SII Investments sold out of BioCryst Pharmaceuticals (BCRX) in Q2 2014, closing a stake of 12,000 shares — an estimated $110K sold.

SII Investments first reported a position in BCRX in Q2 2013 and held it in 4 quarters. The position peaked at $110K in Q1 2014. 103 funds tracked by Wall St. Rank hold BCRX as of Q2 2014.

  • SII Investments reported no remaining BioCryst Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • SII Investments sold 12,000 BioCryst Pharmaceuticals shares in Q2 2014, an estimated $110K.
  • SII Investments first reported a position in BioCryst Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • SII Investments's BioCryst Pharmaceuticals position peaked at $110K in Q1 2014.
  • 103 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2014.

Based on SII Investments's 13F filing for Q2 2014, filed 28 Jul 2014.